New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus1

Findings highlight dose-dependent efficacy of moxidectin in preventing heartworm disease Published Data Demonstrated: Simparica Trio®-treated dogs had significantly lower average heartworm counts than NexGard